LONDON, Feb 13: The University of Oxford has launched the first study to assess the safety and immune responses in children and young adults of its coronavirus vaccine.
The university said that previous trials of its ChAdOx1 nCoV-19 jabs, which are being produced by AstraZeneca and also have a tie-up with the Serum Institute of India, have shown that it is safe, produces strong immune system responses and has high efficacy in all adults.
It would be extending its trials to assess if children and young adults aged 6-17 years also show a good immune response to coronavirus from it.
“While most children are relatively unaffected by coronavirus and are unlikely to become unwell with the infection, it is important to establish the safety and immune response to the vaccine in children and young people as some children may benefit from vaccination,” said Andrew Pollard, professor of Paediatric Infection and Immunity, and Chief Investigator on the Oxford vaccine trial. – PTI